Researcher
Justin Tan is a GIS Innovation Fellow at the Genome Institute of Singapore, Honorary Research Fellow at the Cancer Science Institute of Singapore, NUS, and Senior Research Fellow at the Experimental Drug Development Centre. His group focuses on drugging cell fate, where advanced chemical biology methods are developed and applied to identify chemical modulators that target a class of cancer-causing genes called lineage transcription factors. These lineage factors push normal cells towards a cancer cell fate, and targeting these factors suppresses cancer growth. The ultimate goal is to translate these discoveries into effective cancer therapeutics in the clinic
Related Articles
Exposing the weakness of a tough drug target
1 Jun 2020A*STAR scientists have identified drug compounds that could potentially eradicate an aggressive form of liver